O98.019

Clinical Causes: Transmission of tuberculosis bacteria through airborne particles when an infected person coughs, sneezes, or talks. Reactivation of latent TB infection during pregnancy due to immune system changes. Living in or traveling to areas with high TB prevalence. Close contact with persons diagnosed with active tuberculosis. Pre-existing TB before pregnancy that becomes active during gestation.

Key Symptoms: Persistent cough lasting more than three weeks. Unintended weight loss and loss of appetite. Night sweats and fever. Fatigue and weakness. Chest pain or discomfort. Hemoptysis, which is coughing up blood (less common).

Diagnosis Path: Diagnosing tuberculosis during pregnancy typically involves a combination of clinical evaluation and laboratory tests. Healthcare providers may perform the following: - Tuberculin skin test (TST) or interferon-gamma release assays (IGRAs) to detect latent TB. - Chest X-ray, with appropriate shielding to minimize fetal exposure, to look for lung abnormalities. - Sputum smear microscopy and culture to identify Mycobacterium tuberculosis. - Additional assessments might include blood tests and examination of other relevant tissues if extrapulmonary TB is suspected.

Treatment Protocols: The management of tuberculosis during pregnancy generally involves a comprehensive treatment plan to eliminate the infection while minimizing risks to the mother and fetus. Key aspects include: - Anti-tuberculosis medications, usually including isoniazid, rifampicin, and ethambutol, administered under close medical supervision. - Regular monitoring for drug side effects and efficacy. - Supplementation with vitamin B6 (pyridoxine) to prevent nerve damage caused by isoniazid. - Nutritional support and adequate hydration. - Obstetric care to monitor fetal development and well-being. - Counseling about medication safety and importance of adherence to treatment.